Cellebrite DI Ltd.

94 Shlomo Shmelzer Road

Petah Tikva, Israel

 

October 4, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F Street, NE
Washington, D.C. 20549

 

Attn:	Jan Woo
	Matthew Crispino
Re:	Cellebrite DI Ltd.
	Registration Statement on Form F-1
	Filed September 27, 2021, as amended
	File No. 333-259826

 

Dear Ms. Woo and Mr. Crispino:

 

Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Cellebrite DI Ltd. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on October 6, 2021, or as soon thereafter as practicable.

 

Please call Colin Diamond of White & Case LLP at (212) 819-8754 to provide notice of the effectiveness of the Registration Statement.

 

 

[Signature Page Follows]

 

   

 

	Very truly yours,
	Cellebrite DI Ltd.
	By:	/s/ Yossi Carmil
	Name: Title:	Yossi Carmil Chief Executive Officer

 

 

	cc:	Dana Gerner, Cellebrite DI Ltd.
		Colin Diamond, White & Case LLP